Healthcare Industry News

A Legionnaires' disease outbreak in Central Harlem has sickened at least 67 people and claimed three lives, raising serious concerns about building safety and water system oversight. According to the New York City Health Department, the outbreak has been linked to 11 rooftop cooling towers that tested positive for Legionella, a waterborne bacteria that can cause serious illness when inhaled through contaminated water vapor.

Rejuva Fresh® LLC, a top United States developer in the aesthetic medical device industry, introduces new enhancements for EMSHAPE® NEO PLUS, a revolutionary powerful technology that makes non-invasive body contouring practically effortless.

Dr. Noaman Sanni, a leading ophthalmologist and CEO of Center for Sight New York, has witnessed significant patient and revenue growth after adding Tixel i into his practice. Tixel i, Novoxel's FDA-cleared device, utilizes patented Thermo-Mechanical Action® (TMA) to effectively treat Meibomian Gland Dysfunction (MGD) – a common cause of dry eye – in under two minutes.

A new article in JOJ Ophthalmology confirms Tixel i® provides sustained, strong clinical outcomes for patients with Evaporative Dry Eye Disease (DED) caused by Meibomian Gland Dysfunction (MGD). This FDA-cleared, non-invasive device uses patented Thermo-Mechanical Action® (TMA®) to deliver durable improvements in key indicators, including patient satisfaction and clinical results.

Alameda Health System (AHS) patients experiencing the sudden and frightening symptoms of a stroke will now receive faster and more-integrated care, thanks to the Wilma Chan Highland Hospital Campus’ (WCHHC) recent certification as a stroke center.

As a leading provider of medical solutions in the field of neurosurgery, ZEISS Medical Technology is also dedicated to shaping modern oncology. The company recently received 510(k) clearance from the US Food and Drug Administration (FDA) for INTRABEAM® 700 – a leading-edge platform that provides robotic-assisted precision to support intraoperative radiation therapy (IORT).

A first in human proof of concept phase I clinical study of VAS-101 (Vasceptor®; topical curcumin gel) in sickle cell disease (SCD) is underway. The study is being conducted by the Foundation for Sickle Cell Disease Research (FSCDR) in Hollywood, Florida, under the supervision of the principal investigator, Dr. Gershwin Blyden.

AdventHealth Tampa is the first in the Tampa Bay area to offer a powerful new pump-based treatment option for colorectal cancer that has spread to the liver and for a rare form of cancer that forms in bile ducts within the liver called intrahepatic cholangiocarcinoma.

Stryker a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons.

Since 2010, the NEXTY Awards have honored the highest quality natural products in the world. This year, Qualia Life Sciences is the only supplement brand to have two products, Qualia NAD+ and Qualia Mind.